StockData
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp (UTHR) stock

UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$584.10−3.78 (-0.64%)

Close on Nov 17, 2026Market cap $25.05BP/E 20.9Yield –

United Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

United Therapeutics's EV/EBITDA was 15.2× on Nov 11, 2026, against 11.5× a year earlier. Over the last 5 years it ranged from 6.1× to 15.4×, with a median of 8.8×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202615.2×+3.7
2025Dec 31, 202511.5×+2.3
2024Dec 31, 20249.2×+2.8
2023Dec 29, 20236.5×−3.3
2022Dec 30, 20229.8×−5.6
2021Dec 31, 202115.4×+7.3
2020Dec 31, 20208.1×+4.4
2019Apr 30, 20193.6×−0.5
2018Dec 31, 20184.1×−1.7
2017Dec 29, 20175.9×+1.1
2016Dec 30, 20164.8×−3.6
2015Dec 31, 20158.4×−7.1
2014Dec 31, 201415.6×+4.3
2013Dec 31, 201311.3×+4.6
2012Dec 31, 20126.7×−1.9
2011Dec 30, 20118.6×−11.0
2010Dec 31, 201019.6×–

More United Therapeutics figures

See a number that looks wrong?